Status:
NOT_YET_RECRUITING
Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Mucormycosis
Eligibility:
All Genders
18-100 years
Brief Summary
To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.
Detailed Description
Primary Objective: To establish MD Anderson Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project. * To prospectively identify, collect, and store all isolates causing proven or probable MCM ...
Eligibility Criteria
Inclusion
- Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.
- Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.
Exclusion
- • Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.
Key Trial Info
Start Date :
September 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06878144
Start Date
September 30 2025
End Date
December 31 2032
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030